These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9339399)

  • 1. [Clinical efficacy in pediatrics sinusitis infections of cefditoren pivoxil granule therapy and its in vitro antibacterial activity against clinically isolated strains].
    Sugita R; Deguchi K; Fujimaki Y; Harada S; Shimizu K; Kimura S; Watanabe H; Komatsu N; Okano K; Naito M; Nomura T; Tanaka M; Yoshida Y; Tanaka H; Iwai N; Nakamura H
    Jpn J Antibiot; 1997 Aug; 50(8):727-37. PubMed ID: 9339399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of cefditoren pivoxil in the treatment of acute otitis media due to benzylpenicillin-insensitive Streptococcus pneumoniae].
    Sugita R; Deguchi K; Kimura S; Harada S; Fujimaki Y; Watanabe H; Naito M; Nomura T; Tanaka M; Komatsu N; Shimizu K; Yoshida Y; Okano K
    Jpn J Antibiot; 1996 Apr; 49(4):386-98. PubMed ID: 8786629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Causative organisms of acute otitis media and acute sinusitis in children and their susceptibility of oral beta-lactam antibiotics].
    Takenaka M; Morikawa Y; Nakagawa T; Takashima T; Haruta T; Tsuji T
    Jpn J Antibiot; 1999 Feb; 52(2):162-71. PubMed ID: 10221181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antimicrobial activities of cefcapene against clinical isolates from respiratory tract infections of outpatients].
    Ishihara R; Ishii Y; Suzuki Y; Nakazawa A; Deguchi K; Toyonaga Y
    Jpn J Antibiot; 1998 Jan; 51(1):1-10. PubMed ID: 9557272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic, bacteriological and clinical studies on cefditoren pivoxil in children].
    Tajima T; Kobayashi M; Negishi S; Nishimura S; Yoshida A; Kudo S; Gondou M; Nakayama T; Abe T
    Jpn J Antibiot; 1993 Jul; 46(7):589-95. PubMed ID: 8371494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic, bacteriological and clinical evaluation of cefditoren pivoxil in pediatrics].
    Iwai N; Nakamura H; Miyazu M; Watanabe Y
    Jpn J Antibiot; 1994 Feb; 47(2):181-94. PubMed ID: 8151911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
    Sun HL; Yang QW; Xu YC; Wang H; Xie XL; Chen MJ; Zhang XZ; Liu Y; Ye HF; Sun ZY; Duan Q; Ni YX; Yu YS; Zhao WS; He L; Wang J; Ji P; Liu PP; Zhang LX
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2983-7. PubMed ID: 20137709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of bacterial resistance in the otolaryngology field: results from the Second Nationwide Survey in Japan.
    Suzuki K; Nishimura T; Baba S
    J Infect Chemother; 2003 Mar; 9(1):46-52. PubMed ID: 12673407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinical study on cefditoren pivoxil granules in the pediatric field].
    Mori A; Meguro H; Terashima I; Fujii R
    Jpn J Antibiot; 1993 Jul; 46(7):577-88. PubMed ID: 8371493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antimicrobial activities of cefditoren against clinical isolates obtained from outpatients].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Kumoto T
    Jpn J Antibiot; 1994 Oct; 47(10):1369-78. PubMed ID: 7807697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibacterial activity of oral Cephems against various clinically isolated strains].
    Oshiro T; Fukutomi Y; Takayanagi M; Kusaba K; Nagasawa Z; Aoki Y; Nagayama A
    Jpn J Antibiot; 2003 Dec; 56(6):681-90. PubMed ID: 15007876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteriological, pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field].
    Toyonaga Y; Ishihara T; Sano T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1993 Jul; 46(7):604-28. PubMed ID: 8371496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the safety and efficacy of cefditoren pivoxil fine granules for pediatric use in pediatric patients with acute otitis media].
    Kawamata S; Yamada H; Sato Y; Sasagawa Y; Iwama Y; Matumoto M
    Jpn J Antibiot; 2010 Jun; 63(3):207-23. PubMed ID: 20976878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis].
    Wallrauch-Schwarz C; Milatovic D; Braveny I
    Arzneimittelforschung; 1994 May; 44(5):668-70. PubMed ID: 8024645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibacterial activities of cefmenoxime against recent fresh clinical isolates from patients in sinusitis].
    Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Deguchi K; Oda S; Tanaka S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1995 May; 48(5):602-9. PubMed ID: 7637194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.